Article
Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents.
Journal of negative results in biomedicine - 8 Aug 2014
Zwiegers Pierre, Lee Grace, Shaw Christopher A
Abstract excerpt
BACKGROUND: In vivo animal models of familial amyotrophic lateral sclerosis (fALS) are widely used to delineate the potential role that genetic mutations play in the neurodegenerative process. While these models are extensively used for establishing the safety and efficacy of putative therapeutics during pre-clinical development, effective clinical translation of pharmacological interventions has been largely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
